# Characterization of outer membrane vesicles from Acinetobacter haemolyticus and their role in the dissemination of carbapenem resistance

**Authors:** Elsy Martínez-Gorgonio, Rosa del Carmen Rocha-Gracia, Miguel Castañeda-Lucio, Margarita M. P. Arenas-Hernández, Miguel A. Cevallos, Yolanda Sáenz, Patricia Lozano-Zarain

PMC · DOI: 10.1007/s00430-026-00870-6 · Medical Microbiology and Immunology · 2026-02-27

## TL;DR

This study explores how Acinetobacter haemolyticus uses outer membrane vesicles to spread carbapenem resistance, offering new insights into antibiotic resistance mechanisms.

## Contribution

The study identifies outer membrane vesicles as a novel mechanism for disseminating carbapenem resistance in Acinetobacter haemolyticus.

## Key findings

- Outer membrane vesicles from A. haemolyticus can hydrolyze carbapenem antibiotics and protect sensitive bacteria from their effects.
- OMVs from A. haemolyticus transfer resistance genes to related strains, conferring permanent carbapenem resistance.
- The protein composition of OMVs varies with antibiotic exposure and includes proteins involved in resistance and metabolism.

## Abstract

Species outside the Acinetobacter calcoaceticus–baumannii (Acb) complex have recently emerged as new clinically relevant carbapenem-resistant pathogens, such as A. haemolyticus. A new mechanism that could contribute to the dissemination of this resistance is the secretion of outer membrane vesicles (OMVs). We investigate OMVs secreted by A. haemolyticus AN54, a Mexican clinical strain carrying a plasmid-borne blaNDM−1 gene and by its plasmid-cured derivative AN54Δe. Active secretion of OMVs formed by a lipid membrane, measuring 10–50 nm in both strains, was observed by TEM. The OMVs from AN54 possess hydrolytic capacity against carbapenem. The OMV protein profile varied depending on the antibiotic concentration during induction, with additional protein bands detected at 8 and 32 µg/ml of antibiotic exposure. Mass spectrometry identified proteins involved in different metabolic pathways and in resistance-related processes. The porins, efflux pumps, and ADC enzyme were more abundant in the OMVs from AN54Δe than in those from AN54 harboring the active NDM-1 enzyme. The OMVs protected the sensitive strains from the same and different genera against the antibiotic action for a limited period. However, the OMVs transferred the blaNDM−1-carrying plasmid (pAhaeAN54e) only to the AN54Δe strain, conferring permanent resistance to carbapenems. Together, these findings suggest that OMVs can help protect surrounding bacteria from antibiotic action and serve as vehicles for disseminating resistance genes. These results show the importance of studying OMVs as a novel mechanism for the dissemination of antimicrobial resistance.

The online version contains supplementary material available at 10.1007/s00430-026-00870-6.

## Linked entities

- **Chemicals:** carbapenem (PubChem CID 441133)
- **Species:** Acinetobacter haemolyticus (taxon 29430)

## Full-text entities

- **Genes:** blaNDM-1 [NCBI Gene 13906127], blaNDM-1 [NCBI Gene 14971909], CarO [NCBI Gene 46624246]
- **Diseases:** OMVs (MESH:D015433), HAIs (MESH:D003428), Neisseria gonorrhea (MESH:D006069), cytotoxic (MESH:D064420), infections (MESH:D007239), type (MESH:D006969), antibiotic (MESH:D004761), OMV type B (MESH:D006509)
- **Chemicals:** lipid (MESH:D008055), LPS (MESH:D008070), Imipenem (MESH:D015378), PBS (MESH:D007854), beta-lactam (MESH:D047090), eravacycline (MESH:C571179), glycerol (MESH:D005990), AN54Deltae (-), cefotaxime (MESH:D002439), acetone (MESH:D000096), amino acid (MESH:D000596), Carbapenems (MESH:D015780), Meropenem (MESH:D000077731), phenol (MESH:D019800), phospholipids (MESH:D010743), ticarcillin (MESH:D013982), amoxicillin (MESH:D000658), TSA (MESH:C481298), copper (MESH:D003300), SDS (MESH:D012967), agar (MESH:D000362), Coomassie Brilliant Blue G-250 (MESH:C004692)
- **Species:** Ascomycota sp. N54 (species) [taxon 1585669], Acinetobacter baumannii (species) [taxon 470], Escherichia coli ATCC 25922 (strain) [taxon 1322345], Acinetobacter lwoffii (species) [taxon 28090], Stenotrophomonas maltophilia (species) [taxon 40324], Acinetobacter junii (species) [taxon 40215], Acinetobacter haemolyticus (species) [taxon 29430], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562], Klebsiella pneumoniae (species) [taxon 573], Acinetobacter ursingii (species) [taxon 108980], Pseudomonas aeruginosa (species) [taxon 287]
- **Cell lines:** AN54 — Homo sapiens (Human), Ataxia telangiectasia syndrome, Transformed cell line (CVCL_ZT26), 50,192 — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_7930), ATCC 19,606 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_DQ11), JU0126 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_6961), ATCC 25,922 — Homo sapiens (Human), Transformed cell line (CVCL_7307)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12948810/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12948810/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12948810/full.md

---
Source: https://tomesphere.com/paper/PMC12948810